Aksense logo — Point-of-Care Testing for Infectious Diseases

Aksense

Point-of-Care Testing for Infectious Diseases

Founded 2017 Turkey Turkey 4 employees Seed Total: $160.00K Health Care, Medical Devices

General Information

Company Name Aksense
Founded Year 2017
Location Turkey Turkey +1
Employees 4
Industries Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when Aksense moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aksense

Aksense, founded in 2017, is an innovator in the Health Care and Medical Devices sectors, with headquarters in Turkey. The company is making significant strides in the medical field with its pioneering product—an electronic biosensor aimed at Point-of-Care Testing for Infectious Diseases.

Aksense's flagship device facilitates rapid, one-minute blood tests for healthcare-associated infections, eliminating the need for a lab or expert intervention. This not only stands to save lives but also reduces time and healthcare costs, presenting a significant value proposition for healthcare providers globally.

Following a successful Seed Round investment on 09 May 2022, backed by SOSV, Aksense is well-positioned to expand its market reach and continue its development efforts. Investors should note the company's potential to disrupt traditional infection testing processes with its portable and time-efficient solution.

Taxonomy: Point-of-Care Testing, Healthcare-Associated Infections, Rapid Diagnostic Testing, Electronic Biosensor, Portable Medical Device, Infection Detection, Biotechnology Innovation, Medical Device Development, Infectious Disease Management, Blood Test Innovation, Life-Saving Technology, Cost-Effective Healthcare Solutions

Services & Products

Rapid Diagnosis in Minutes
Portable Diagnostic Device
Accurate Infection Identification

Target Customers

Healthcare Providers Hospitals Long-term Care Facilities Clinics

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
09 May 2022
Seed Round •••••• - 15 Jan 2020
Pre Seed Round •••••• 1
Investor
16 Oct 2019
Non Equity Assistance •••••• 1
Investor
05 Jan 2019

Aksense Alternatives & Competitors

View All Alternatives
Aksense vs
Leuko
Leuko United States

Non-invasive white blood cell monitoring

Series A
11 employees
Biotechnology, Health Care
Aksense vs
Crown Laboratories
Crown Laboratories United States

Crown Laboratories is a CLIA-certified clinical laboratory that specializes in diagnosis of syndromi...

11-50 employees
Health Care
Aksense vs

Empowering precision in pathogen diagnosis with advanced genetic testing technology, ensuring timely...

Series C
1 employees
Health Care

FAQ About Aksense

Point-of-Care Testing for Infectious Diseases
Aksense was founded in 2017.
Aksense is headquartered in Turkey.
Aksense operates in the following industries: Health Care, Medical Devices.
Aksense has approximately 4 employees.
Aksense has completed 4 funding rounds, raising a total of $160.00K. The latest funding stage is Seed.
Aksense offers: Rapid Diagnosis in Minutes, Portable Diagnostic Device, Accurate Infection Identification.
Top alternatives and competitors to Aksense include Leuko, Crown Laboratories, genskey, Astek Diagnostics, POCRAME SAS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aksense and Leuko are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aksense and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy